FibroBiologics (FBLG) Current Assets (2022 - 2026)
FibroBiologics (FBLG) posted quarterly Current Assets of $5.8 million for Q2 2026, down 42.52% year-over-year from $10.2 million in Q2 2025, and up 101.38% on a QoQ basis from $2.9 million in Q1 2026.
FibroBiologics (FBLG) Current Assets (2022 - 2026) Analysis & Trends
FibroBiologics has reported Current Assets for 5 years, with the latest figure at $5.8 million in Q2 2026.
- Current Assets for Q2 2026 came in at $5.8 million, down 42.52% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.8 million (down 42.52% YoY), and the FY2025 annual result was $6.3 million, down 55.38% from the prior year.
- Current Assets grew to $5.8 million in Q2 2026, from $2.9 million in the prior quarter.
- Over five years, Current Assets peaked at $14.2 million in Q4 2024 and troughed at $2.6 million in Q4 2022.
- A 5-year average of $7.5 million and a median of $7.4 million in 2024 frame the typical range for Current Assets.
- The widest annual swing landed in 2023, when Current Assets soared 251.05%; it then sank 68.85% in 2026.
- A 5-year view of Current Assets shows it stood at $2.6 million in 2022, then soared by 251.05% to $9.2 million in 2023, then jumped by 54.4% to $14.2 million in 2024, then slumped by 55.38% to $6.3 million in 2025, then decreased by 7.86% to $5.8 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $5.8 million in Q2 2026, $2.9 million in Q1 2026, and $6.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 1.76 Bn |
| 10 | FibroBiologics | 8.91 Mn | 8.91 Mn | - | 5.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.85 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 6.35 Mn |
| Sep 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 10.18 Mn |
| Mar 31, 2025 | 9.33 Mn |
| Dec 31, 2024 | 14.23 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Dec 31, 2023 | 9.22 Mn |
| Dec 31, 2022 | 2.63 Mn |